Revolution Medicines Inc (NASDAQ: RVMD) on Friday, soared 0.18% from the previous trading day, before settling in for the closing price of $44.93. Within the past 52 weeks, RVMD’s price has moved between $24.62 and $62.40.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 11.11% over the last five years. The company achieved an average annual earnings per share of 9.81%. With a float of $151.65 million, this company’s outstanding shares have now reached $167.75 million.
The firm has a total of 378 workers. Let’s measure their productivity. In terms of profitability, gross margin is -17912.67%, operating margin of -88031.94%, and the pretax margin is -76377.09%.
Revolution Medicines Inc (RVMD) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Revolution Medicines Inc is 16.84%, while institutional ownership is 81.77%. The most recent insider transaction that took place on Dec 05 ’24, was worth 59,999,962. In this transaction Director of this company bought 1,304,347 shares at a rate of $46.00, taking the stock ownership to the 2,096,612 shares. Before that another transaction happened on Nov 15 ’24, when Company’s General Counsel sold 2,554 for $55.13, making the entire transaction worth $140,811. This insider now owns 43,080 shares in total.
Revolution Medicines Inc (RVMD) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 9.81% per share during the next fiscal year.
Revolution Medicines Inc (NASDAQ: RVMD) Trading Performance Indicators
Revolution Medicines Inc (RVMD) is currently performing well based on its current performance indicators. A quick ratio of 14.24 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 11111.06.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.59, a number that is poised to hit -0.99 in the next quarter and is forecasted to reach -3.97 in one year’s time.
Technical Analysis of Revolution Medicines Inc (RVMD)
Analysing the last 5-days average volume posted by the [Revolution Medicines Inc, RVMD], we can find that recorded value of 1.37 million was lower than the volume posted last year of 1.4 million. As of the previous 9 days, the stock’s Stochastic %D was 3.83%. Additionally, its Average True Range was 2.24.
During the past 100 days, Revolution Medicines Inc’s (RVMD) raw stochastic average was set at 22.37%, which indicates a significant increase from 3.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 53.89% in the past 14 days, which was higher than the 42.90% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $52.15, while its 200-day Moving Average is $42.57. Now, the first resistance to watch is $45.45. This is followed by the second major resistance level at $45.90. The third major resistance level sits at $46.37. If the price goes on to break the first support level at $44.53, it is likely to go to the next support level at $44.06. Should the price break the second support level, the third support level stands at $43.61.
Revolution Medicines Inc (NASDAQ: RVMD) Key Stats
Market capitalization of the company is 8.22 billion based on 168,219K outstanding shares. Right now, sales total 11,580 K and income totals -436,370 K. The company made 0 K in profit during its latest quarter, and -156,290 K in sales during its previous quarter.
